A polymorphism of the human matrix gamma-carboxyglutamic acid protein promoter alters binding of an activating protein-1 complex and is associated with altered transcription and serum levels.
about
Quantitative prediction of NF-kappa B DNA-protein interactions.Arterial calcification in chronic kidney disease: key roles for calcium and phosphateUnderstanding the genetics of coronary artery disease through the lens of noninvasive imagingGRECOS Project (Genotyping Recurrence Risk of Stroke): The Use of Genetics to Predict the Vascular Recurrence After Stroke.Genetics in arterial calcification: pieces of a puzzle and cogs in a wheel.Association of kidney function and uncarboxylated matrix Gla protein: data from the Heart and Soul Study.Functional impact of a single-nucleotide polymorphism in the OPRD1 promoter region.Abundant raw material for cis-regulatory evolution in humans.The physiology of vitamin K nutriture and vitamin K-dependent protein function in atherosclerosis.Reactive oxygen species, inflammation and calcium oxalate nephrolithiasis.Molecular mechanisms mediating vascular calcification: role of matrix Gla protein.Unified theory on the pathogenesis of Randall's plaques and plugsQuantifying DNA-protein binding specificities by using oligonucleotide mass tags and mass spectroscopy.Association of matrix Gla protein gene allelic polymorphisms (G(-7)→A, T(-138)→C and Thr(83)→Ala) with acute coronary syndrome in the Ukrainian population.A haplotype of the angiotensinogen gene is associated with hypertension in african americans.Matrix gla protein gene polymorphism is associated with increased coronary artery calcification progressionVitamin K status and vascular calcification: evidence from observational and clinical studies.Matrix Gla protein is associated with risk factors for atherosclerosis but not with coronary artery calcificationVitamin K-dependent proteins, warfarin, and vascular calcificationMatrix Gla protein polymorphisms are associated with coronary artery calcification in men.Polymorphisms in MGP gene and their association with lead toxicity.Gene-drug interaction in strokeAngiotensinogen gene polymorphism at -217 affects basal promoter activity and is associated with hypertension in African-Americans.Sp proteins and Runx2 mediate regulation of matrix gla protein (MGP) expression by parathyroid hormone.JunB as a potential mediator of PTHrP actions: new gene targets Ephrin B1 and VCAM-1The Fos-related antigen Fra-1 is an activator of bone matrix formation.SNP haplotyping technique for evaluation of MGP 5' UTR power in osteoblast cells.Molecular cloning of the Matrix Gla Protein gene from Xenopus laevis. Functional analysis of the promoter identifies a calcium sensitive region required for basal activity.Association of Matrix Gla protein gene (rs1800801, rs1800802, rs4236) polymorphism with vascular calcification and atherosclerotic disease: a meta-analysis.Calcium oxalate nephrolithiasis and expression of matrix GLA protein in the kidneys.Phylogenetic analysis of ALAD and MGP genes related to lead toxicity.Undercarboxylated matrix GLA protein levels are decreased in dialysis patients and related to parameters of calcium-phosphate metabolism and aortic augmentation index.CD40-1C>T polymorphism (rs1883832) is associated with brain vessel reocclusion after fibrinolysis in ischemic stroke.Computational prediction and analysis of protein γ-carboxylation sites based on a random forest method.Status of Single Nucleotide Polymorphism of Matrix Gla Protein Gene (rs4236) in Nephrolithiasis: A Preliminary Study in Indian Population.Polymorphism in the human matrix Gla protein gene is associated with the progression of vascular calcification in maintenance hemodialysis patients.No association between MGP rs1800802 polymorphism and stenosis of the coronary artery.Assessment of matrix Gla protein, Klotho gene polymorphisms, and oxidative stress in chronic kidney disease.
P2860
Q24298906-99D0CF0E-8C2B-4EC4-B7DA-48FBADB0B3C4Q26827655-E8917FE1-6C93-405F-984F-624D608B654CQ26999418-8B91296F-C208-45D0-B893-099BC692B559Q30252625-2A3994F2-CCF6-426F-AD62-C5D5B94081DDQ33352008-CEF428D7-627A-4584-8506-A32A424CB403Q33407103-218F0710-F8B8-4A41-8DAF-93127D0515D6Q33875900-D7B33003-F68C-4C54-B07F-B861B1398FAFQ34157325-4DA3597E-AB2F-4964-863C-B89FCAA69C10Q34378782-4957A5CF-BED8-4B25-89A5-CB59383C287CQ34454068-21A8DAD0-9777-426A-8EB9-08915DE74A26Q34570670-0240C0C3-6101-4D7E-9D7E-623EBE6A2203Q35216521-42007591-2E1B-40AF-89F8-D2918FD1DFC2Q35652208-47D40037-404B-486C-AC86-6B8BAF705EC2Q36058977-0F9A1D7D-7DB1-4F3C-9DA5-ECE2C99BFF33Q36107897-A4968B8A-2932-4EA7-8DBE-6D6FD7ED4479Q36651164-77F9C8E7-5C48-41E3-900F-7B2AB32BDA4DQ36828717-335B8A88-B1B5-4E18-BC95-7874F22A2332Q36925289-8F4E76FA-DFAB-47DF-8138-23299D158BA0Q37170124-25449042-A07A-4032-B68D-A2D98BD79781Q37252395-0F2B48E7-540B-4D87-8198-9CA033669D92Q37329901-24B91297-E005-40CF-8889-970CBAABAAAAQ37963892-014B5AE1-3847-4AA2-BE5F-4F2661591681Q38363948-04873138-1E09-4FF3-B7BE-A1992F7348C8Q39869550-28884EAD-CE47-44CF-9775-D1C16A5860EFQ39887544-FAEADFEB-00EA-4F3C-B3B6-8CFE84336638Q39959355-12131E71-9368-4490-9DDF-2DAA5BF691E1Q40668505-CD3F12A3-BFF5-40F4-9943-8F71EF99716AQ40738366-A3C3B749-EC31-44B5-B9C5-EE71BD36B6D3Q41459499-728622E9-7741-447D-B050-7B34CC7F2C3AQ41895002-5A746E4D-F9A8-458A-8C71-117248E0A7EEQ43293868-A19A00EC-9BFC-47ED-99F4-DCBE7FC03721Q46279181-FD80196E-FF83-4A1F-AB71-8DECD459F3F6Q48185202-29D3B985-A39F-48AA-9AAC-91EC382906F4Q51330285-5F9C33F8-2B40-48B6-8067-26A4C8C83016Q52649472-AB9D4113-4BE2-4E5C-A881-60B487662002Q53116786-B760500F-6C49-45C9-A102-592955FDBDC6Q54264948-AA7C920F-D6FA-4556-89F8-151A65E85585Q54352759-16034931-738A-4EB2-8C4E-573CECF5F815
P2860
A polymorphism of the human matrix gamma-carboxyglutamic acid protein promoter alters binding of an activating protein-1 complex and is associated with altered transcription and serum levels.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
A polymorphism of the human ma ...... ranscription and serum levels.
@en
A polymorphism of the human ma ...... ranscription and serum levels.
@nl
type
label
A polymorphism of the human ma ...... ranscription and serum levels.
@en
A polymorphism of the human ma ...... ranscription and serum levels.
@nl
prefLabel
A polymorphism of the human ma ...... ranscription and serum levels.
@en
A polymorphism of the human ma ...... ranscription and serum levels.
@nl
P2093
P2860
P356
P1476
A polymorphism of the human ma ...... ranscription and serum levels.
@en
P2093
Farzaneh-Far A
O'Shaughnessy KM
Proudfoot D
Shanahan CM
Weissberg PL
P2860
P304
32466-32473
P356
10.1074/JBC.M104909200
P407
P577
2001-06-25T00:00:00Z